Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Positive association of CD36 gene variants with the visual outcome of photodynamic therapy in polypoidal choroidal vasculopathy.

Molecular vision - 1 Jan 2012

Honda Shigeru, Bessho Hiroaki, Kondo Naoshi, Kusuhara Sentaro, Tsukahara Yasutomo, Negi Akira

Abstract excerpt

PURPOSE: To clarify the association between cluster of differentiation 36 (CD36) gene polymorphisms and the response to photodynamic therapy (PDT) in polypoidal choroidal vasculopathy (PCV). METHODS: One hundred and thirty-seven patients with PCV were enrolled. The patients were treated with PDT and followed up for more than 6 months. Retreatments were performed every 3 months as needed based on findings from...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiogenesis Inhibitors
Share to CD36 Antigens

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Choroid

Share to Choroidal Neovascularization

Share to Fluorescein Angiography

Share to Photochemotherapy

Share to Photosensitizing Agents

Share to Tomography, Optical Coherence

Source

Open in PubMed Open full text

Identifiers

PMID: 23213279
PMCID: PMC3513185

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Positive association of CD36 gene variants with the visual outcome of photodynamic therapy in polypoidal choroidal vasculopathy.PMID 23213279Read ↗

The association of CD36 variants with polypoidal choroidal vasculopathy compared to typical neovascular age-related macular degeneration.Semantic proximity Read ↗

Genetic variants in pigment epithelium-derived factor influence response of polypoidal choroidal vasculopathy to photodynamic therapy.Semantic proximity Read ↗

Association of LOC387715 A69S genotype with visual prognosis after photodynamic therapy for polypoidal choroidal vasculopathy.Semantic proximity Read ↗

Genetic associations in polypoidal choroidal vasculopathy: a systematic review and meta-analysis.Semantic proximity Read ↗

The association of polypoidal choroidal vasculopathy clinical phenotypes with previously reported genetic markers.Semantic proximity Read ↗

Genetic predictors of response to photodynamictherapy.Semantic proximity Read ↗

Association of ARMS2 genotype with response to anti-vascular endothelial growth factor treatment in polypoidal choroidal vasculopathy.Semantic proximity Read ↗

C2 rs547154 polymorphism and polypoidal choroidal vasculopathy susceptibility: a meta-analysis.Semantic proximity Read ↗

Two-year visual outcome of polypoidal choroidal vasculopathy treated with photodynamic therapy combined with intravitreal injections of ranibizumab.Semantic proximity Read ↗

Predictive role of C677T MTHFR polymorphism in variable efficacy of photodynamic therapy for neovascular age-related macular degeneration.Semantic proximity Read ↗

Development of an automated system for the detection of genotype in polypoidal choroidal vasculopathy using retinal image phenotype.Semantic proximity Read ↗

Prognostic phenotypic and genotypic factors associated with photodynamic therapy response in patients with age-related macular degenerationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.